Investing Ideas
/
Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies

Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies

Results

2 new

Companies with a Value score of at least 3, ordered by Value score

75 companies

Genomma Lab Internacional. de

Market Cap: Mex$17.2b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

LAB B

Mex$17.59

-3.2%

-35.4%

Jazz Pharmaceuticals

Market Cap: Mex$10.3b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

JAZZ N

Mex$2,500.00

n/a

Vaxart

Market Cap: Mex$117.4m

A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States.

VXRT *

Mex$12.00

n/a

CSPC Pharmaceutical Group

Market Cap: Mex$69.4b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

1093 N

Mex$15.69

-27.0%

GSK

Market Cap: Mex$57.0b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

GSK1 N

Mex$356.95

n/a

Zai Lab

Market Cap: Mex$3.5b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

ZLAB N

Mex$810.00

n/a

Exact Sciences

Market Cap: Mex$12.2b

Provides cancer screening and diagnostic test products in the United States and internationally.

EXAS *

Mex$890.12

n/a

CSL

Market Cap: Mex$87.2b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

CSL N

Mex$2,414.77

n/a

Regeneron Pharmaceuticals

Market Cap: Mex$72.3b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

REGN *

Mex$12,155.00

-18.6%

Merck

Market Cap: Mex$230.5b

Operates as a healthcare company worldwide.

MRK *

Mex$1,698.09

2.3%

-12.2%

Novo Nordisk

Market Cap: Mex$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

NOVOB N

Mex$881.88

-4.7%

-56.5%

Johnson & Johnson

Market Cap: Mex$480.8b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

JNJ *

Mex$3,598.85

2.3%

17.5%

Pfizer

Market Cap: Mex$142.6b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

PFE *

Mex$460.99

-1.2%

-8.2%

Organon

Market Cap: Mex$2.0b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

OGN *

Mex$138.40

-0.07%

n/a

Zoetis

Market Cap: Mex$52.4b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

ZTS *

Mex$2,218.00

0.4%

-38.1%

Incyte

Market Cap: Mex$20.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

INCY *

Mex$1,945.50

n/a

CureVac

Market Cap: Mex$1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

CVAC N

Mex$98.10

58.2%

Grifols

Market Cap: Mex$6.4b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

GRF N

Mex$257.03

n/a

BeiGene

Market Cap: Mex$14.0b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

BGNE N

Mex$2,858.16

n/a

Perrigo

Market Cap: Mex$3.7b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

PRGO N

Mex$557.52

n/a

Novo Nordisk

Market Cap: Mex$1.4t

NVO N

Mex$881.49

-2.4%

-57.1%

Halozyme Therapeutics

Market Cap: Mex$8.3b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

HALO *

Mex$1,275.01

n/a

CRISPR Therapeutics

Market Cap: Mex$5.3b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

CRSP N

Mex$940.00

-21.0%

n/a

Viatris

Market Cap: Mex$12.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

VTRS *

Mex$201.00

1.6%

-19.6%

Elanco Animal Health

Market Cap: Mex$8.8b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

ELAN *

Mex$262.00

n/a

Royalty Pharma

Market Cap: Mex$22.6b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

RPRX N

Mex$719.95

-0.7%

36.2%

Gilead Sciences

Market Cap: Mex$154.0b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

GILD *

Mex$2,264.00

2.2%

26.8%

Sarepta Therapeutics

Market Cap: Mex$1.8b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

SRPT *

Mex$355.00

8.4%

n/a

Astellas Pharma

Market Cap: Mex$2.8t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

4503 N

Mex$204.11

n/a

Telix Pharmaceuticals

Market Cap: Mex$4.7b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

TLX1 N

Mex$302.55

n/a

Biogen

Market Cap: Mex$24.2b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

BIIB *

Mex$3,060.00

9.7%

-12.0%

Ardelyx

Market Cap: Mex$1.4b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARDX *

Mex$122.20

n/a

Bristol-Myers Squibb

Market Cap: Mex$95.3b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

BMY *

Mex$899.00

1.4%

-23.2%

ACADIA Pharmaceuticals

Market Cap: Mex$4.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ACAD *

Mex$400.00

n/a

Bayer

Market Cap: Mex$27.5b

Operates as a life science company worldwide.

BAYN N

Mex$626.01

4.3%

n/a

Amgen

Market Cap: Mex$184.0b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

AMGN *

Mex$6,280.00

4.8%

12.2%

Page 1 of 3